Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2353 (LINC02353) is a long intergenic non-coding RNA (lincRNA), which are RNA transcripts longer than 200 nucleotides that do not overlap protein-coding genes and do not encode proteins[1][5]. LINC02353 is annotated in genomic databases as a distinct, autonomously transcribed gene. Its specific biological functions, molecular interactors, disease associations, and druggability have not been characterized in the current biomedical literature. In general, lincRNAs play broad roles in gene regulatory networks, epigenetic modulation, and RNA-protein scaffolding, often displaying tissue- and disease-specific expression patterns. However, as of the current data, the functional and therapeutic relevance of LINC02353 remains unknown[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2353 (LINC02353).